二甲双胍治疗银屑病的研究进展

doi:10.35541/cjd.20201257

Abstract

Abstract: 【Abstract】 Metformin, the first-line treatment of type 2 diabetes, has been also increasingly used in the treatment of some skin diseases, such as psoriasis. This review summarizes therapeutic mechanisms of and clinical research progress in metformin in the treatment of psoriasis, aiming to provide ideas and methods for the treatment of psoriasis, especially psoriasis complicated by metabolic diseases.

Key words: Psoriasis, Metformin, Therapy, NF-kappa B, Mechanistic target of rapamycin, Extracellular signal-regulated kinase, Signal transducing activator of transcription, Nucleotide-binding oligomerization domain-like receptor protein 3

Chen Xiaomin, Zhang Jingzhan, Ding Yuan, Kang Xiaojing. Metformin in the treatment of psoriasis[J]. Chinese Journal of Dermatology, 2023, 56(8): 799-802.doi:10.35541/cjd.20201257

References ［29］

［1］	Zhang C, Xiao C, Dang E, et al. CD100⁃plexin⁃B2 promotes the inflammation in psoriasis by activating NF⁃κB and the inflammasome in keratinocytes［J］. J Invest Dermatol, 2018,138（2）:375⁃383. doi: 10.1016/j.jid.2017.09.005.
［2］	Yan S, Xu Z, Lou F, et al. NF⁃κB⁃induced microRNA⁃31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis［J］. Nat Commun, 2015,6:7652. doi: 10.1038/ncomms8652.
［3］	Müller A, Hennig A, Lorscheid S, et al. IκBζ is a key transcriptional regulator of IL⁃36⁃driven psoriasis⁃related gene expression in keratinocytes［J］. Proc Natl Acad Sci U S A, 2018,115（40）:10088⁃10093. doi: 10.1073/pnas.1801377115.
［4］	Ba W, Xu Y, Yin G, et al. Metformin inhibits pro⁃inflammatory responses via targeting nuclear factor⁃κB in HaCaT cells［J］. Cell Biochem Funct, 2019,37（1）:4⁃10. doi: 10.1002/cbf.3367.
［5］	Glossmann H, Reider N. A marriage of two "Methusalem" drugs for the treatment of psoriasis?: arguments for a pilot trial with metformin as add⁃on for methotrexate［J］. Dermatoendocrinol, 2013,5（2）:252⁃263. doi: 10.4161/derm.23874.
［6］	Buerger C. Epidermal mTORC1 signaling contributes to the pathogenesis of psoriasis and could serve as a therapeutic target［J］. Front Immunol, 2018,9:2786. doi: 10.3389/fimmu. 2018. 02786.
［7］	Bürger C, Shirsath N, Lang V, et al. Blocking mTOR signalling with rapamycin ameliorates imiquimod⁃induced psoriasis in mice［J］. Acta Derm Venereol, 2017,97（9）:1087⁃1094. doi: 10. 2340/00015555⁃2724.
［8］	Varshney P, Saini N. PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL⁃17A mediated inflammatory response in psoriasis［J］. Biochim Biophys Acta Mol Basis Dis, 2018,1864（5 Pt A）:1795⁃1803. doi: 10.1016/j.bbadis.2018.02.003.
［9］	Gargalionis AN, Malakou LS, Adamopoulos C, et al. Polycystin⁃1 downregulation induces ERK⁃dependent mTOR pathway activation in a cellular model of psoriasis［J］. Biochim Biophys Acta Mol Basis Dis, 2018,1864（10）:3468⁃3476. doi: 10.1016/j.bbadis.2018.07.036.
［10］	Liu Y, Yang F, Ma W, et al. Metformin inhibits proliferation and proinflammatory cytokines of human keratinocytes in vitro via mTOR⁃signaling pathway［J］. Pharm Biol, 2016,54（7）:1173⁃1178. doi: 10.3109/13880209.2015.1057652.
［11］	Yang Q, Liu X, Liu Q, et al. Roles of mTORC1 and mTORC2 in controlling γδ T1 and γδ T17 differentiation and function［J］. Cell Death Differ, 2020,27（7）:2248⁃2262. doi: 10.1038/s41418⁃020⁃0500⁃9.
［12］	Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation［J］. J Clin Invest, 2015,125（1）:25⁃32. doi: 10.1172/JCI73939.
［13］	Balato A, Lembo S, Ayala F, et al. Mechanistic target of rapamycin complex 1 is involved in psoriasis and regulated by anti⁃TNF⁃α treatment［J］. Exp Dermatol, 2017,26（4）:325⁃327. doi: 10.1111/exd.13267.
［14］	Buerger C, Shirsath N, Lang V, et al. Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation［J/OL］. PLoS One, 2017,12（7）:e0180853. doi: 10.1371/journal.pone.0180853.
［15］	Wu J, Xiao S, Ren J, et al. A unified mitochondria mechanistic target of rapamycin acyl⁃coenzyme A dehydrogenase 10 signal relay modulation for metformin growth inhibition in human immortalized keratinocytes cells［J/OL］. J Cell Biochem, 2018. （2018⁃11⁃11）［2020⁃09⁃16］. https://pubmed.ncbi.nlm.nih.gov/30206977/. doi:10.1002/jcb.27481.
［16］	Wu Y, Liu L, Bian C, et al. MicroRNA let⁃7b inhibits keratinocyte differentiation by targeting IL⁃6 mediated ERK signaling in psoriasis［J］. Cell Commun Signal, 2018,16（1）:58. doi: 10.1186/s12964⁃018⁃0271⁃9.
［17］	Li W, Ma W, Zhong H, et al. Metformin inhibits proliferation of human keratinocytes through a mechanism associated with activation of the MAPK signaling pathway［J］. Exp Ther Med, 2014,7（2）:389⁃392. doi: 10.3892/etm.2013.1416.
［18］	Wang X, Li R, Zhao X, et al. Metformin promotes HaCaT cell apoptosis through generation of reactive oxygen species via Raf⁃1⁃ERK1/2⁃Nrf2 inactivation［J］. Inflammation, 2018,41（3）:948⁃958. doi: 10.1007/s10753⁃018⁃0749⁃z.
［19］	Kvist⁃Hansen A, Hansen PR, Skov L. Systemic treatment of psoriasis with JAK inhibitors: a review［J］. Dermatol Ther （Heidelb）, 2020,10（1）:29⁃42. doi: 10.1007/s13555⁃019⁃00347⁃w.
［20］	Nogueira M, Puig L, Torres T. JAK inhibitors for treatment of psoriasis: focus on selective TYK2 inhibitors［J］. Drugs, 2020,80（4）:341⁃352. doi: 10.1007/s40265⁃020⁃01261⁃8.
［21］	Andrés RM, Hald A, Johansen C, et al. Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3⁃Ser727 phosphorylation as a modulator of transcriptional activity［J］. Exp Dermatol, 2013,22（5）:323⁃328. doi: 10.1111/exd.12128.
［22］	Clarysse K, Pfaff CM, Marquardt Y, et al. JAK1/3 inhibition preserves epidermal morphology in full⁃thickness 3D skin models of atopic dermatitis and psoriasis［J］. J Eur Acad Dermatol Venereol, 2019,33（2）:367⁃375. doi: 10.1111/jdv.15301.
［23］	Calautti E, Avalle L, Poli V. Psoriasis: a STAT3⁃centric view［J］. Int J Mol Sci, 2018,19（1）: 171⁃185. doi: 10.3390/ijms19010171.
［24］	苏蓓蓓, 甘泉, 甘才斌. 二甲双胍对银屑病样小鼠模型皮损炎症状态及磷酸化Stat3蛋白表达的影响［J］. 中华皮肤科杂志, 2019,52（7）:475⁃480. doi: 10.3760/cma.j.issn.0412⁃4030.2019. 07.006.
［25］	Tsuji G, Hashimoto⁃Hachiya A, Yen VH, et al. Metformin inhibits IL⁃1β secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis［J］. Cell Death Discov, 2020,6:11. doi: 10.1038/s41420⁃020⁃0245⁃8.
［26］	Su YJ, Chen TH, Hsu CY, et al. Safety of metformin in psoriasis patients with diabetes mellitus: a 17⁃year population⁃based real⁃world cohort study［J］. J Clin Endocrinol Metab, 2019,104（8）:3279⁃3286. doi: 10.1210/jc.2018⁃02526.
［27］	Wu CY, Shieh JJ, Shen JL, et al. Association between antidiabetic drugs and psoriasis risk in diabetic patients: results from a nationwide nested case⁃control study in Taiwan［J］. J Am Acad Dermatol, 2015,72（1）:123⁃130. doi: 10.1016/j.jaad.2014. 08.042.
［28］	El⁃Gharabawy RM, Ahmed AS, Al⁃Najjar AH. Mechanism of action and effect of immune⁃modulating agents in the treatment of psoriasis［J］. Biomed Pharmacother, 2017,85:141⁃147. doi: 10.1016/j.biopha.2016.11.105.
［29］	Singh S, Bhansali A. Randomized placebo control study of insulin sensitizers （metformin and pioglitazone） in psoriasis patients with metabolic syndrome （topical treatment cohort）［J］. BMC Dermatol, 2016,16（1）:12. doi: 10.1186/s12895⁃016⁃0049⁃y.

[1]	. Two cases of childhood generalized pustular psoriasis treated with secukinumab [J]. Chinese Journal of Dermatology, 2023, 56(9): 874-876.
[2]	Xiao-Jie SUN Yi Liu. Anti-androgen drugs in the treatment of skin diseases [J]. Chinese Journal of Dermatology, 2023, 56(9): 882-885.
[3]	. S100A10 protein expression in psoriatic lesions and its effect on psoriasis-like skin inflammation in mouse models [J]. Chinese Journal of Dermatology, 2023, 56(9): 839-844.
[4]	Yu-Qian WANG Jianjun Qiao Hong FANG. Comparison of the latest Chinese and international guidelines/consensus on diagnosis and treatment of alopecia areata [J]. Chinese Journal of Dermatology, 2023, 56(9): 885-888.
[5]	. Atopic dermatitis-like lesions appearing after interleukin-17 antagonist therapy in 4 cases of psoriasis: case analysis and literature review [J]. Chinese Journal of Dermatology, 2023, 56(9): 845-848.
[6]	Yuan Xingang, Ni Sili, Zhang Jian, Luo Xiaoyan, Wang Hua. Improving diagnosis and treatment of melanocytic nevi in children: an urgent need [J]. Chinese Journal of Dermatology, 2023, 56(8): 782-786.
[7]	Zhong Jiemin, Shao Lei, Liang Yimin, Huang Qiongxiao, Xia Manqi, Liu Yumei. Comparative study on efficacy and safety of single microneedle radiofrequency versus photodynamic therapy in the treatment of inflammatory lesions of moderate to severe facial acne vulgaris [J]. Chinese Journal of Dermatology, 2023, 56(8): 751-755.
[8]	Song Zhiqiang, Chen Qiquan, Ge Lan. Insights into the progress in targeted therapy of atopic dermatitis from the perspective of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(8): 718-723.
[9]	Tang Zhiming, Jing Mengqing, Lu Lu, Shan Xiao, Zhang Cuixia, Zhang Xiaoyu, Meng Sa. Effect of Xidi Liangxue recipe on the proliferation and apoptosis of HaCaT cells through the lncRNA NEAT1/miR-485-5p/STAT3 regulatory network [J]. Chinese Journal of Dermatology, 2023, 56(7): 642-650.
[10]	Committee on Psoriasis, Chinese Society of Dermatology. Guideline for the diagnosis and treatment of psoriasis in China （2023 edition） [J]. Chinese Journal of Dermatology, 2023, 56(7): 573-625.
[11]	Li Yue, Wu Jinyan, Yuan Ruoyue, Yang Quyang, Zhao Xiansheng, Zhu Ningwen. Cell therapy for hereditary epidermolysis bullosa [J]. Chinese Journal of Dermatology, 2023, 56(7): 698-702.
[12]	Jiang Xiaoyan, Gao Min, Zhang Xiaoyan, Liu Ningyuan. Interleukin-17 and interleukin-23 inhibitors in the treatment of pustular psoriasis [J]. Chinese Journal of Dermatology, 2023, 56(7): 689-692.
[13]	Shan Ying, Chang Xiaotong, Zuo Yagang. Epitope spreading in autoimmune bullous diseases [J]. Chinese Journal of Dermatology, 2023, 56(7): 702-705.
[14]	Li Rong, Zhang Jiaan, Chen Kun. Photoelectric therapy for rosacea [J]. Chinese Journal of Dermatology, 2023, 56(5): 468-470.
[15]	Jin Shiying, Shi Jinjun, Gao Qi, Chen Mei, Dong Zhengbang, Yan Qiao, Li Jijian, Wang Fei. High-frequency ultrasonography-assisted evaluation of treatment outcomes of erysipelas: a prospective controlled study [J]. Chinese Journal of Dermatology, 2023, 56(5): 434-438.

Metformin in the treatment of psoriasis

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［29］

Related Articles 15

Metrics

Comments

Recommended 10